Yasuo Ohashi

41.7k total citations · 8 hit papers
596 papers, 23.8k citations indexed

About

Yasuo Ohashi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yasuo Ohashi has authored 596 papers receiving a total of 23.8k indexed citations (citations by other indexed papers that have themselves been cited), including 190 papers in Oncology, 121 papers in Pulmonary and Respiratory Medicine and 89 papers in Surgery. Recurrent topics in Yasuo Ohashi's work include Cancer Treatment and Pharmacology (53 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (48 papers) and Colorectal Cancer Treatments and Studies (47 papers). Yasuo Ohashi is often cited by papers focused on Cancer Treatment and Pharmacology (53 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (48 papers) and Colorectal Cancer Treatments and Studies (47 papers). Yasuo Ohashi collaborates with scholars based in Japan, United States and Australia. Yasuo Ohashi's co-authors include Mitsuru Sasako, Toshiharu Yamaguchi, Toshifusa Nakajima, Taira Kinoshitá, Atsushi Nashimoto, Masashi Fujii, Shinichi Sakuramoto, Hirohito Sone, Shiro Tanaka and Nobuhiro Yamada and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Yasuo Ohashi

587 papers receiving 23.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine

2007 1.9k citations Shinichi Sakuramoto, Mitsuru Sasako et al. profile →
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

2011 1.1k citations Mitsuru Sasako, Shinichi Sakuramoto et al. Journal of Clinical Oncology profile →
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

2016 742 citations Yasuo Ohashi et al. The Lancet profile →
Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

2000 688 citations Yasuo Ohashi, Tadao Kakizoe et al. The Lancet profile →
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

2006 686 citations Yasuo Ohashi et al. The Lancet profile →
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

2006 515 citations Yasuo Ohashi et al. profile →
Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial

2015 381 citations Noriaki Ohuchi, Akihiko Suzuki et al. The Lancet profile →
Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project

2016 326 citations Yasuo Ohashi et al. profile →

Peers

Countries citing papers authored by Yasuo Ohashi

Since Specialization

Citations

This map shows the geographic impact of Yasuo Ohashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Ohashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Ohashi more than expected).

Fields of papers citing papers by Yasuo Ohashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Ohashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Ohashi. The network helps show where Yasuo Ohashi may publish in the future.

Co-authorship network of co-authors of Yasuo Ohashi

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Ohashi. A scholar is included among the top collaborators of Yasuo Ohashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Ohashi. Yasuo Ohashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effect of a Multifactorial Intervention on Fracture in Patients With Type 2 Diabetes: Subanalysis of the J-DOIT3 Study 2021 ·The Journal of Clinical Endocrinology & Metabolism ·Takayoshi Sasako, Kohjiro Ueki, (unknown), Yukiko Okazaki, Yasuhiro Takeuchi, Yasuo Ohashi, Mitsuhiko Noda, Takashi Kadowaki	5
2	A follow-up study of a randomized controlled study evaluating safety and efficacy of leuprorelin acetate every-3-month depot for 2 versus 3 or more years with tamoxifen for 5 years as adjuvant treatment in premenopausal patients with endocrine-responsive breast cancer 2021 ·Breast Cancer ·Junichi Kurebayashi, Eiichi Shiba, Tatsuya Toyama, Hiroshi Matsumoto, M. Okazaki, Tadashi Nomizu, Tohru Ohtake, Takaaki Fujii, Yasuo Ohashi	5
3	One-year incidence of venous thromboembolism, bleeding, and death in patients with solid tumors newly initiating cancer treatment: Results from the Cancer-VTE Registry 2021 ·Thrombosis Research ·Yasuo Ohashi, Masataka Ikeda, Hideo Kunitoh, Mitsuru Sasako, Takuji Okusaka, Hirofumi Mukai, Keiichi Fujiwara, Mashio Nakamura, Mari S. Oba, Tetsuya Kimura, (unknown), Atsushi Takita, Masato Sakon	16
4	A Correlation Analysis Between Metabolism-related Genes and Treatment Response to S-1 as First-line Chemotherapy for Metastatic Breast Cancer: The SELECT BC-EURECA Study 2021 ·Clinical Breast Cancer ·Tsutomu Takashima, Fumikata Hara, Takayuki Iwamoto, Yukari Uemura, Shozo Ohsumi, Daisuke Yotsumoto, Yasuo Hozumi, Takanori Watanabe, Tsuyoshi Saito, Kenichi Watanabe, Junji Tsurutani, Tatsuya Toyama, Hiromitsu Akabane, Reiki Nishimura, Naruto Taira, Yasuo Ohashi, Hirofumi Mukai	1
5	Comparison of an AC‐taxane versus AC‐free regimen and paclitaxel versus docetaxel in patients with lymph node‐positive breast cancer: Final results of the National Surgical Adjuvant Study of Breast Cancer 02 trial, a randomized comparative phase 3 study 2017 ·Cancer ·Toru Watanabe, Masaru Kuranami, Kenichi Inoue, Norikazu Masuda, Kenjiro Aogi, Shinji Ohno, Hiroji Iwata, Hirofumi Mukai, Yukari Uemura, Yasuo Ohashi	28
6	Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial breakdown → 2015 ·The Lancet ·Noriaki Ohuchi, Akihiko Suzuki, Tomotaka Sobue, Masaaki Kawai, Seiichiro Yamamoto, Yingfang Zheng, (unknown), Hiroshi Saito, Shinichi Kuriyama, Eriko Tohno, Tokiko Endo, Akira Fukao, Ichiro Tsuji, Takuhiro Yamaguchi, Yasuo Ohashi, Mamoru Fukuda, Takanori Ishida	381
7	Fruit Intake and Incident Diabetic Retinopathy with Type 2 Diabetes 2013 ·Epidemiology ·Shiro Tanaka, Yukio Yoshimura, Ryo Kawasaki, Chiemi Kamada, Sachiko Tanaka, Chika Horikawa, Yasuo Ohashi, Atsushi Araki, Hideki Ito, Yasuo Akanuma, Nobuhiro Yamada, Hidetoshi Yamashita, Hirohito Sone	65
8	Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer breakdown → 2011 ·Journal of Clinical Oncology ·Mitsuru Sasako, Shinichi Sakuramoto, Hitoshi Katai, Taira Kinoshitá, Hiroshi Furukawa, Toshiharu Yamaguchi, Atsushi Nashimoto, Masashi Fujii, Toshifusa Nakajima, Yasuo Ohashi	1055
9	Safety of adjuvant trastuzumab for HER-2-overexpressing elderly breast cancer patients: a multicenter cohort study 2011 ·Breast Cancer ·Masataka Sawaki, Hirofumi Mukai, Nahomi Tokudome, Takahiro Nakayama, Naruto Taira, Toshiro Mizuno, Yutaka Yamamoto, (unknown), Toru Watanabe, Yukari Uemura, Yasuo Ohashi	11
10	Doubly robust estimation of the generalized impact fraction 2011 ·Biostatistics ·Masataka Taguri, Yutaka Matsuyama, Yasuo Ohashi, Atsushi Harada, H. Ueshima	14
11	Effect of Orally Administered Bovine Lactoferrin on the Growth of Adenomatous Colorectal Polyps in a Randomized, Placebo-Controlled Clinical Trial 2009 ·Cancer Prevention Research ·Takahiro Kozu, Gen Iinuma, Yasuo Ohashi, Yutaka Saito, Takayuki Akasu, Daizo Saito, David B. Alexander, Masaaki Iigo, Tadao Kakizoe, Hiroyuki Tsuda	98
12	Favourable prognosis with modified dosing of docetaxel and cisplatin in Japanese patients with ovarian cancer. 2009 ·PubMed ·Daisuke Aoki, Yoh Watanabe, Toshiko Jobo, Kimio Ushijima, Kiyoshi Hasegawa, Nobuyuki Susumu, Nao Suzuki, Rui Aoki, Seiji Isonishi, Satoru Sagae, Bunpei Ishizuka, Toshiharu Kamura, Yasuhiro Udagawa, Hiroshi Hoshiai, Yasuo Ohashi, Kazunori Ochiai, Kiichiro Noda	5
13	The New Worldwide Definition of Metabolic Syndrome Is Not a Better Diagnostic Predictor of Cardiovascular Disease in Japanese Diabetic Patients Than the Existing Definitions 2006 ·Diabetes Care ·Hirohito Sone, Sachiko Tanaka, Shun Ishibashi, Yoshimitsu Yamasaki, Shinichi Oikawa, Hideki Ito, Yasushi Saitō, Yasuo Ohashi, Yasuo Akanuma, Nobuhiro Yamada, (unknown)	53
14	Estimation of Occurrence Peaks of Adverse Events Using Hazard Functions 2003 ·Akira Fukushima, (unknown), (unknown), Masaki Sano, (unknown), Yasuo Ohashi	0
15	Evaluation of the Effect of an Educational Diabetes Videotape 2001 ·(unknown), Shuji Hashimoto, Yasuo Ohashi, Nobuaki Kuzuya, Yasunori Kanazawa	1
16	SECONDARY PREVENTION OF CEREBRAL INFARCTION WITH CILOSTAZOL-A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLED, LONG TERM, RANDOMIZED STUDY (CILOSTAZOL STROKE PREVENTION STUDY, CSPS) 2000 ·Fumio Gotoh, Hideo Tohgi, S Hirai, (unknown), Yasuo Fukuuchi, (unknown), Yuki Shinohara, Eiji Itoh, T Matsuda, (unknown), Takenori Yamaguchi, (unknown), Yasuo Ohashi	1
17	Inter- and Intra-Examiner Reliability of Clinical Parameters Used in periodontics. 1999 ·Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology) ·(unknown), (unknown), (unknown), (unknown), (unknown), Akiko Matsumura, Yukihiro Numabe, Kyuichi Kamoi, Kazuyuki Noguchi, Hisashi Watanabe, Isao Ishikawa, Hiroshi Matsuyama, Yasuo Ohashi, Akihiro Mishima	1
18	Efficacy Evaluation of Analgesic Agents used for Cancer Pain Management by Visual Analogue Scale:A Survey by Questionnaire to Physicians, Nurses and Patients 1999 ·(unknown), Yasuo Ohashi	1
19	[Reproducibility and validity of a semi-quantitative food frequency questionnaire]. 1998 ·PubMed ·(unknown), Satoru Hashimoto, Yasuo Ohashi, (unknown), (unknown), (unknown)	8
20	Questionnaires Relating to the Transmission of Drug Information Regarding the Interaction of Sorivudine. 1994 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Chikuma Hamada, Daisuke Koide, (unknown), Yasuo Ohashi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact